Technical Analysis for JNCE - Jounce Therapeutics, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| See historical JNCE trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Jan 18 | Fell Below 20 DMA | Bearish | 0.00% |
| Jan 18 | Fell Below 50 DMA | Bearish | 0.00% |
| Jan 18 | New Downtrend | Bearish | 0.00% |
| Jan 18 | Stochastic Sell Signal | Bearish | 0.00% |
| Jan 18 | Expansion Pivot Sell Setup | Bearish Swing Setup | 0.00% |
| Jan 18 | Wide Range Bar | Range Expansion | 0.00% |
| Jan 18 | Wide Bands | Range Expansion | 0.00% |
| Jan 18 | Overbought Stochastic | Strength | 0.00% |
| Jan 18 | Down 3 Days in a Row | Weakness | 0.00% |
| Jan 17 | 1,2,3 Pullback Bullish | Bullish Swing Setup | -20.00% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 2018-11-12
- Sector: Healthcare
- Industry: Bio Therapeutic Drugs
Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T cells found in a range of solid tumors. It also developing JTX-4014 for use in future combinations with JTX-2011, as well as for use in combination with other future product candidates. Jounce Therapeutics, Inc. is based in Cambridge, United States.
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more JNCE news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 29.25 |
| 52 Week Low | 2.66 |
| Average Volume | 338,477 |
| 200-Day Moving Average | 8.4114 |
| 50-Day Moving Average | 4.1406 |
| 20-Day Moving Average | 3.9605 |
| 10-Day Moving Average | 4.599 |
| Average True Range | 0.4029 |
| ADX | 30.63 |
| +DI | 20.9913 |
| -DI | 25.8698 |
| Chandelier Exit (Long, 3 ATRs ) | 3.7913 |
| Chandelier Exit (Short, 3 ATRs ) | 3.8687 |
| Upper Bollinger Band | 5.5048 |
| Lower Bollinger Band | 2.4162 |
| Percent B (%b) | 0.45 |
| BandWidth | 77.985103 |
| MACD Line | 0.1819 |
| MACD Signal Line | 0.1276 |
| MACD Histogram | 0.0543 |
| Fundamentals | Value |
|---|---|
| Market Cap | 122.19 Million |
| Num Shares | 32.2 Million |
| EPS | 0.03 |
| Price-to-Earnings (P/E) Ratio | 126.67 |
| Price-to-Sales | 5.66 |
| Price-to-Book | 2.51 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.30 | ||||
| Resistance 3 (R3) | 5.46 | 5.11 | 5.05 | ||
| Resistance 2 (R2) | 5.11 | 4.73 | 5.04 | 4.97 | |
| Resistance 1 (R1) | 4.46 | 4.50 | 4.29 | 4.30 | 4.88 |
| Pivot Point | 4.11 | 4.11 | 4.03 | 4.04 | 4.11 |
| Support 1 (S1) | 3.46 | 3.73 | 3.29 | 3.30 | 2.72 |
| Support 2 (S2) | 3.11 | 3.50 | 3.04 | 2.63 | |
| Support 3 (S3) | 2.46 | 3.11 | 2.55 | ||
| Support 4 (S4) | 2.30 |
